Prevalence of the Myasthenia Gravis Disease Prevalence of the disease, Myasthenia Gravis
The cause of the Myasthenia Gravis disease
Myasthenia Gravis clinical manifestations
Prevention of Myasthenia Gravis
Treatment of Myasthenia Gravis. Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal muscles. Common symptoms include weakness of the muscles that control the eye and eyelid, facial expressions, chewing, talking, and swallowing. Weakness tends to increase during periods of activity and improve after periods of rest. The condition results from a defect in the transmission of nerve impulses to muscles, which is due to the presence of antibodies against acetylcholine.[1] The exact reason this occurs is not known.
